ArticleOncotarget2018

Evaluation of vascular events in patients with myeloproliferative syndromes and mutations of either the januskinase-2 or calreticulin gene at the university hospital Krems from 2008 to 2015.

Sarah Hintermair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.